The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2019
Filed:
Oct. 25, 2017
Applicant:
Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);
Inventors:
Kin Tso, San Francisco, CA (US);
Hui Li, Santa Clara, CA (US);
Yan Chen, Foster City, CA (US);
Rose Yen, San Francisco, CA (US);
Vanessa Taylor, San Francisco, CA (US);
Thilo Heckrodt, San Francisco, CA (US);
Rajinder Singh, Belmont, CA (US);
Simon Shaw, Oakland, CA (US);
Assignee:
Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 413/14 (2006.01); C07D 403/14 (2006.01); C07D 403/12 (2006.01); C07D 405/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01);
Abstract
Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitors and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.